687 related articles for article (PubMed ID: 26807900)
21. The Efficiency of Cyclosporine A-Eluting Contact Lenses for the Treatment of Dry Eye.
Choi JH; Li Y; Jin R; Shrestha T; Choi JS; Lee WJ; Moon MJ; Ju HT; Choi W; Yoon KC
Curr Eye Res; 2019 May; 44(5):486-496. PubMed ID: 30580651
[TBL] [Abstract][Full Text] [Related]
22. A semifluorinated alkane (F4H5) as novel carrier for cyclosporine A: a promising therapeutic and prophylactic option for topical treatment of dry eye.
Gehlsen U; Braun T; Notara M; Krösser S; Steven P
Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):767-775. PubMed ID: 28091781
[TBL] [Abstract][Full Text] [Related]
23. Cevimeline-induced anti-inflammatory effect through upregulations of mucins in the ocular surface of a dry eye mouse model.
Kim CE; Kim YJ; Hwang MW; Park YJ; Yang J
Biomed Pharmacother; 2021 Jul; 139():111571. PubMed ID: 33857915
[TBL] [Abstract][Full Text] [Related]
24. Effect of Topical 5-Aminoimidazole-4-carboxamide-1-β-d-Ribofuranoside in a Mouse Model of Experimental Dry Eye.
Sung MS; Li Z; Cui L; Choi JS; Choi W; Park MJ; Park SH; Yoon KC
Invest Ophthalmol Vis Sci; 2015 May; 56(5):3149-58. PubMed ID: 26024098
[TBL] [Abstract][Full Text] [Related]
25. Sjögren's syndrome associated dry eye in a mouse model is ameliorated by topical application of integrin α4 antagonist GW559090.
Contreras-Ruiz L; Mir FA; Turpie B; Krauss AH; Masli S
Exp Eye Res; 2016 Feb; 143():1-8. PubMed ID: 26463157
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-1 receptor-1-deficient mice show attenuated production of ocular surface inflammatory cytokines in experimental dry eye.
Narayanan S; Corrales RM; Farley W; McDermott AM; Pflugfelder SC
Cornea; 2008 Aug; 27(7):811-7. PubMed ID: 18650668
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic Effect of MK2 Inhibitor on Experimental Murine Dry Eye.
Wu Y; Bu J; Yang Y; Lin X; Cai X; Huang C; Zheng X; Ouyang W; Li W; Zhang X; Liu Z
Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4898-4907. PubMed ID: 28973340
[TBL] [Abstract][Full Text] [Related]
28. Cyclosporine inhibits apoptosis in experimental murine xerophthalamia conjunctival epithelium.
Sun J; Wang J
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(4):469-71. PubMed ID: 17120751
[TBL] [Abstract][Full Text] [Related]
29. Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca.
Strong B; Farley W; Stern ME; Pflugfelder SC
Cornea; 2005 Jan; 24(1):80-5. PubMed ID: 15604871
[TBL] [Abstract][Full Text] [Related]
30. [Therapeutic effects of Pyranoprofen on the mouse dry eye induced by topical medication of Benzalkonium Chloride].
He H; Liu ZG; Lin ZR; Liu XC; He H; Xiao QG
Zhonghua Yan Ke Za Zhi; 2012 Jan; 48(1):33-40. PubMed ID: 22490914
[TBL] [Abstract][Full Text] [Related]
31. Effects of chondrocyte-derived extracellular matrix in a dry eye mouse model.
Kim CE; Oh HN; Lee JH; Yang JW
Mol Vis; 2015; 21():1210-23. PubMed ID: 26604661
[TBL] [Abstract][Full Text] [Related]
32. Effect of chitosan-N-acetylcysteine conjugate in a mouse model of botulinum toxin B-induced dry eye.
Hongyok T; Chae JJ; Shin YJ; Na D; Li L; Chuck RS
Arch Ophthalmol; 2009 Apr; 127(4):525-32. PubMed ID: 19365035
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of the mineral oil and hyaluronic acid mixture eye drops in murine dry eye.
Choi JH; Kim JH; Li Z; Oh HJ; Ahn KY; Yoon KC
Korean J Ophthalmol; 2015 Apr; 29(2):131-7. PubMed ID: 25829831
[TBL] [Abstract][Full Text] [Related]
34. Tear production and ocular surface changes in experimental dry eye after elimination of desiccating stress.
Yoon KC; Ahn KY; Choi W; Li Z; Choi JS; Lee SH; Park SH
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7267-73. PubMed ID: 21849424
[TBL] [Abstract][Full Text] [Related]
35. Effects of silk fibroin in murine dry eye.
Kim CE; Lee JH; Yeon YK; Park CH; Yang J
Sci Rep; 2017 Mar; 7():44364. PubMed ID: 28281688
[TBL] [Abstract][Full Text] [Related]
36. The effects of 2% rebamipide ophthalmic solution on the tear functions and ocular surface of the superoxide dismutase-1 (sod1) knockout mice.
Ohguchi T; Kojima T; Ibrahim OM; Nagata T; Shimizu T; Shirasawa T; Kawakita T; Satake Y; Tsubota K; Shimazaki J; Ishida S
Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7793-802. PubMed ID: 24168989
[TBL] [Abstract][Full Text] [Related]
37. Effects of eye drops containing a mixture of omega-3 essential fatty acids and hyaluronic acid on the ocular surface in desiccating stress-induced murine dry eye.
Li Z; Choi JH; Oh HJ; Park SH; Lee JB; Yoon KC
Curr Eye Res; 2014 Sep; 39(9):871-8. PubMed ID: 24559509
[TBL] [Abstract][Full Text] [Related]
38. Topical cyclosporine in thyroid orbitopathy-related dry eye: clinical findings, conjunctival epithelial apoptosis, and MMP-9 expression.
Gürdal C; Genç I; Saraç O; Gönül I; Takmaz T; Can I
Curr Eye Res; 2010 Sep; 35(9):771-7. PubMed ID: 20795858
[TBL] [Abstract][Full Text] [Related]
39. The effects of 3% diquafosol sodium eye drop application on meibomian gland and ocular surface alterations in the Cu, Zn-superoxide dismutase-1 (Sod1) knockout mice.
Ikeda K; Simsek C; Kojima T; Higa K; Kawashima M; Dogru M; Shimizu T; Tsubota K; Shimazaki J
Graefes Arch Clin Exp Ophthalmol; 2018 Apr; 256(4):739-750. PubMed ID: 29484560
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of combined 0.05% cyclosporine and 1% methylprednisolone treatment for chronic dry eye.
Byun YJ; Kim TI; Kwon SM; Seo KY; Kim SW; Kim EK; Park WC
Cornea; 2012 May; 31(5):509-13. PubMed ID: 19730097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
